Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology — Cincinnati, Ohio

Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology is a clinical research site located in Cincinnati, Ohio, United States 45227.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology has participated in 1 clinical trials.

Therapeutic areas: Atherosclerosis.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology?

Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology conducted?

Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology has 1 clinical trials on record. Their work covers Atherosclerosis.

Is Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology accredited by Crixeo Health?

Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metabolic And Atherosclerosis Research Center/ Medpace Clinical Pharmacology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.